Pathogenic Roles of TSH-Receptor Antibodies in Graves’ Disease
Since the discovery of long acting thyroid stimulator, the significance of circulating abnormal thyroid stimulators or TSH-receptor antibodies in untreated patients with Graves’ disease has been investigated extensively by numerous investigators. However, the pathogenic roles of TSH-receptor antibodies for thyrotoxicosis of Graves’ disease are still not completely elucidated.
KeywordsThyroid Gland Human Thyroid Autoimmune Thyroid Disease Human Thyroid Tissue Thyroid Membrane
Unable to display preview. Download preview PDF.
- 1.N. Kuzuya, S.C. Chiu, H. Ikeda, H. Ikeda, H. Uchimura, K. Ito, and S. Nagataki, Correlation between Thyroid Stimulators and 3, 5, 3’- Triiodothyronine Suppressibility in Patients during Treatment for Hyperthyroidism with Thionamide Drugs: Comparison of Assays by Thyroid-Stimulating and Thyrotropin-Displacing Activities, J Clin Endocrinol Metab. 48: 706 (1979).PubMedCrossRefGoogle Scholar
- 2.N. Yokoyama, M. Izumi, and S. Nagataki, Heterogeneity of Graves 1 IgG: Comparison of TSH Receptor Antibodies in Serum and in Culture Supernatants of Lymphocytes Transformed by EB Virus Infection, J Clin Endocrinol Metab. (in press).Google Scholar
- 3.S. Nagataki, Pathogenic Factors of Graves 1 disease, in: “Current problems in Thyroid reseach,” N. Ui, K. Torizuka, S. Nagataki, and K. Miyai, ed., Excerpta Medica, Amsterdam-Oxford-Princeton (1982).Google Scholar
- 8.M. Matsunaga, K. Eguchi, T. Fukuda, A. Kurata, H. Tezuka, C. Shimomura, T. Otsubo, N. Ishikawa, K. Ito, and S. Nagataki, Class II Major Histocompatibility Complex Antigen Expression and Cellular Interaction in Thyroid Glands of Graves’ Disease, J Clin Endocrinol Metab. 62: 723 (1986).PubMedCrossRefGoogle Scholar